Table III.
Assessment |
||||||
---|---|---|---|---|---|---|
Baseline |
3 Months |
12 Months |
||||
Mild TBI | OI | Mild TBI | OI | Mild TBI | OI | |
Cognitive PCS | ||||||
Total PTSD symptoms | 0.32* | 0.45* | 0.45* | 0.60* | 0.41* | 0.42* |
Re-experiencing symptoms | 0.16 | 0.20* | 0.40* | 0.35* | 0.21* | 0.44* |
Avoidance symptoms | 0.20* | 0.23* | 0.27* | 0.49* | 0.19 | 0.39* |
Hyperarousal symptoms | 0.38* | 0.36* | 0.49* | 0.61* | 0.46* | 0.32* |
Somatic PCS | ||||||
Total PTSD symptoms | 0.46* | 0.43* | 0.29* | 0.48* | 0.24* | 0.56* |
Re-experiencing symptoms | 0.23* | 0.29* | 0.30* | 0.32* | 0.13 | 0.57* |
Avoidance symptoms | 0.25* | 0.28* | 0.15 | 0.33* | 0.15 | 0.52* |
Hyperarousal symptoms | 0.29* | 0.31* | 0.30* | 0.56* | 0.24* | 0.48* |
p < .05; italics indicate significant differences between groups, p < .05